{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:56:44Z","timestamp":1777604204221,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T00:00:00Z","timestamp":1684627200000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021564","name":"UNICANCER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.lungcan.2022.05.004","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T21:10:07Z","timestamp":1652821807000},"page":"31-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome"],"prefix":"10.1016","volume":"169","author":[{"given":"Alice","family":"Mogenet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Barlesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Besse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Michiels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Tran-Dien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Girard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Mazieres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarisse","family":"Audigier-Valette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Locatelli-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maud","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Gestraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abderaouf","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Jacquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Yara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Greillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Planchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Bieche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Tomasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2022.05.004_b0005","article-title":"Global epidemiology of lung cancer","volume":"85","author":"Barta","year":"2019","journal-title":"Ann. Glob. Health."},{"issue":"8","key":"10.1016\/j.lungcan.2022.05.004_b0010","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2022.05.004_b0015","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","article-title":"Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA)","volume":"3","author":"Sperduto","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2022.05.004_b0020","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1988.6.9.1474","article-title":"Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis","volume":"6","author":"S\u00f8rensen","year":"1988","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2022.05.004_b0025","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1158\/1078-0432.CCR-14-2082","article-title":"Bevacizumab in patients with nonsquamous non-small cell lung cancer and asymptomatic, untreated brain metastases (BRAIN): a nonrandomized, phase II study","volume":"21","author":"Besse","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2022.05.004_b0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ctrv.2016.03.009","article-title":"The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer","volume":"45","author":"Peters","year":"2016","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.lungcan.2022.05.004_b0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.lungcan.2015.01.020","article-title":"Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers","volume":"88","author":"Rangachari","year":"2015","journal-title":"Lung Cancer."},{"issue":"12","key":"10.1016\/j.lungcan.2022.05.004_b0040","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.3390\/ijms17122132","article-title":"EGFR and KRAS mutations predict the incidence and outcome of brain metastases in non-small cell lung cancer","volume":"17","author":"Tomasini","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.lungcan.2022.05.004_b0045","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.lungcan.2022.05.004_b0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jtho.2020.10.128","article-title":"Mutational landscape and evolutionary pattern of liver and brain metastasis in lung adenocarcinoma","volume":"16","author":"Jiang","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"50","key":"10.1016\/j.lungcan.2022.05.004_b0055","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.18632\/oncotarget.27837","article-title":"Comparative genomic analysis of primary tumors and paired brain metastases in lung cancer patients by whole exome sequencing: a pilot study","volume":"11","author":"Tomasini","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2022.05.004_b0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2119\/molmed.2015.00207","article-title":"Blood-brain barrier remodeling during brain metastasis formation","volume":"22","author":"Wrobel","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/j.lungcan.2022.05.004_b0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","article-title":"Crossing the blood-brain barrier: recent advances in drug delivery to the brain","volume":"31","author":"Patel","year":"2017","journal-title":"CNS Drugs"},{"issue":"33","key":"10.1016\/j.lungcan.2022.05.004_b0070","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1200\/JCO.2018.78.3118","article-title":"CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated egfr-mutated advanced non-small-cell lung cancer","volume":"36","author":"Reungwetwattana","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2022.05.004_b0075","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1093\/annonc\/mdy405","article-title":"Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study","volume":"29","author":"Gadgeel","year":"2018","journal-title":"Ann. Oncol."},{"issue":"08","key":"10.1016\/j.lungcan.2022.05.004_b0080","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4236\/jct.2019.108057","article-title":"Predictive factors of intracranial response of immune checkpoint inhibitors in patients with brain metastasis from non-small cell lung cancer","volume":"10","author":"Bermudez","year":"2019","journal-title":"J. Cancer Ther."},{"key":"10.1016\/j.lungcan.2022.05.004_b0085","doi-asserted-by":"crossref","first-page":"102067","DOI":"10.1016\/j.ctrv.2020.102067","article-title":"Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic","volume":"89","author":"Vilari\u00f1o","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.lungcan.2022.05.004_b0090","doi-asserted-by":"crossref","first-page":"S823","DOI":"10.1016\/j.annonc.2020.08.1587","article-title":"1273P Durvalumab (D) compared to maintenance chemotherapy (SoC) in patients (pts) with metastatic non-small cell lung cancer (NSCLC): results from the randomized SAFIR02 LUNG-IMMUNO trial","volume":"31","author":"Barlesi","year":"2020","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2022.05.004_b0095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.3564","article-title":"Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas","volume":"48","author":"Campbell","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lungcan.2022.05.004_b0100","doi-asserted-by":"crossref","first-page":"e925147","DOI":"10.12659\/MSM.925147","article-title":"TPX2 promotes metastasis and serves as a marker of poor prognosis in non-small cell lung cancer","volume":"26","author":"Zhou","year":"2020","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.lungcan.2022.05.004_b0105","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201539","article-title":"miR-152\/TNS1 axis inhibits non-small cell lung cancer progression through Akt\/mTOR\/RhoA pathway","volume":"41","author":"Duan","year":"2021","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.lungcan.2022.05.004_b0110","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2147\/CMAR.S192385","article-title":"Aberrant CEACAM19 expression is associated with metastatic phenotype in penile cancer","volume":"11","author":"Hu","year":"2019","journal-title":"Cancer Manage. Res."},{"key":"10.1016\/j.lungcan.2022.05.004_b0115","first-page":"916","article-title":"Transferrin receptor 1 in cancer: a new sight for cancer therapy","volume":"8","author":"Shen","year":"2018","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.lungcan.2022.05.004_b0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00109-008-0414-3","article-title":"Transferrin-receptor-mediated iron accumulation controls proliferation and glutamate release in glioma cells","volume":"87","author":"Chirasani","year":"2009","journal-title":"J. Mol. Med. (Berl)."},{"issue":"11","key":"10.1016\/j.lungcan.2022.05.004_b0125","doi-asserted-by":"crossref","first-page":"e0166593","DOI":"10.1371\/journal.pone.0166593","article-title":"Aberrations in the iron regulatory gene signature are associated with decreased survival in diffuse infiltrating gliomas","volume":"11","author":"Weston","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.lungcan.2022.05.004_b0130","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.18632\/oncotarget.23275","article-title":"Elevated transgelin\/TNS1 expression is a potential biomarker in human colorectal cancer","volume":"9","author":"Zhou","year":"2018","journal-title":"Oncotargetics"},{"issue":"1","key":"10.1016\/j.lungcan.2022.05.004_b0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-019-0419-2","article-title":"WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling","volume":"17","author":"Jiang","year":"2019","journal-title":"Cell Commun. Signal."},{"issue":"11","key":"10.1016\/j.lungcan.2022.05.004_b0140","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3390\/cancers11111622","article-title":"RAD52 functions in homologous recombination and its importance on genomic integrity maintenance and cancer therapy","volume":"11","author":"Nogueira","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lungcan.2022.05.004_b0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-017-0611-1","article-title":"Cdk5 links with DNA damage response and cancer","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Cancer"},{"issue":"21","key":"10.1016\/j.lungcan.2022.05.004_b0150","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.7150\/jca.25967","article-title":"CDK5 functions as a tumor promoter in human lung cancer","volume":"9","author":"Zeng","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.lungcan.2022.05.004_b0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41419-019-1407-6","article-title":"BCL-2 family isoforms in apoptosis and cancer","volume":"10","author":"Warren","year":"2019","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.lungcan.2022.05.004_b0160","doi-asserted-by":"crossref","first-page":"e1674605","DOI":"10.1080\/2162402X.2019.1674605","article-title":"Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer","volume":"8","author":"Stamm","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.lungcan.2022.05.004_b0165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ebiom.2019.03.045","article-title":"PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1\/JNK signaling pathway","volume":"42","author":"Bai","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lungcan.2022.05.004_b0170","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1007\/s12035-017-0525-3","article-title":"Tale of the Good and the Bad Cdk5: remodeling of the Actin Cytoskeleton in the Brain","volume":"55","author":"Shah","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lungcan.2022.05.004_b0175","doi-asserted-by":"crossref","first-page":"12586","DOI":"10.1523\/JNEUROSCI.0341-13.2013","article-title":"AGAP3 and Arf6 regulate trafficking of AMPA receptors and synaptic plasticity","volume":"33","author":"Oku","year":"2013","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.lungcan.2022.05.004_b0180","doi-asserted-by":"crossref","first-page":"e40053","DOI":"10.1371\/journal.pone.0040053","article-title":"Suppression of glioma progression by Egln3","volume":"7","author":"Sciorra","year":"2012","journal-title":"PLoS ONE"},{"issue":"448","key":"10.1016\/j.lungcan.2022.05.004_b0185","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar2238","article-title":"BCL3 expression promotes resistance to alkylating chemotherapy in gliomas","volume":"10","author":"Wu","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lungcan.2022.05.004_b0190","doi-asserted-by":"crossref","unstructured":"Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013;155:462\u2013477. https:\/\/doi.org\/10.1016\/j.cell.2013.09.034.","DOI":"10.1016\/j.cell.2013.09.034"},{"issue":"6","key":"10.1016\/j.lungcan.2022.05.004_b0195","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/neuonc\/nox191","article-title":"EGFR heterogeneity and implications for therapeutic intervention in glioblastoma","volume":"20","author":"Eskilsson","year":"2018","journal-title":"Neuro Oncol."},{"issue":"14","key":"10.1016\/j.lungcan.2022.05.004_b0200","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1158\/0008-5472.CAN-17-3571","article-title":"HP1\u03b3 promotes lung adenocarcinoma by downregulating the transcription-repressive regulators NCOR2 and ZBTB7A","volume":"78","author":"Alam","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2022.05.004_b0205","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13287-020-01667-x","article-title":"Runx1t1 promotes the neuronal differentiation in rat hippocampus","volume":"11","author":"Zou","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.lungcan.2022.05.004_b0210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1878-0261.12829","article-title":"Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer","volume":"15","author":"He","year":"2021","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2022.05.004_b0215","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/MPA.0b013e3182152bda","article-title":"RUNX1T1: a novel predictor of liver metastasis in primary pancreatic endocrine neoplasms","volume":"40","author":"Nasir","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.lungcan.2022.05.004_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101978","article-title":"KRAS as a druggable target in NSCLC: rising like a phoenix after decades of development failures","volume":"85","author":"Friedlaender","year":"2020","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.lungcan.2022.05.004_b0225","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/jnci\/djr523","article-title":"Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome","volume":"104","author":"Ihle","year":"2012","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.lungcan.2022.05.004_b0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.lungcan.2018.07.013","article-title":"KRAS-Mutant non-small cell lung cancer: from biology to therapy","volume":"124","author":"Ferrer","year":"2018","journal-title":"Lung Cancer"},{"issue":"13","key":"10.1016\/j.lungcan.2022.05.004_b0235","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","article-title":"KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors","volume":"383","author":"Hong","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.lungcan.2022.05.004_b0240","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2022.05.004_b0245","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.lungcan.2015.11.011","article-title":"Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: analysis from the European FRAME study","volume":"90","author":"Moro-Sibilot","year":"2015","journal-title":"Lung Cancer."},{"key":"10.1016\/j.lungcan.2022.05.004_b0250","doi-asserted-by":"crossref","first-page":"e14110","DOI":"10.1097\/MD.0000000000014110","article-title":"Effect of pemetrexed on brain metastases from nonsmall cell lung cancer with wild-type and unknown EGFR status","volume":"98","author":"Yu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lungcan.2022.05.004_b0255","doi-asserted-by":"crossref","unstructured":"P. Tomasini J. Egea M. Souquet-Bressand L. Greillier F. Barlesi Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases Ther Adv Respir Dis. 13 2019 1753466619831906 10.1177\/1753466619831906.","DOI":"10.1177\/1753466619831906"},{"issue":"2","key":"10.1016\/j.lungcan.2022.05.004_b0260","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non\u2013small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2022.05.004_b0265","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1426-2","article-title":"Immunotherapy of brain metastases: breaking a \u201cdogma\u201d","volume":"38","author":"Di Giacomo","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.lungcan.2022.05.004_b0270","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","article-title":"Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial","volume":"17","author":"Goldberg","year":"2016","journal-title":"Lancet Oncol. juill"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222004330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222004330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:59:29Z","timestamp":1759237169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500222004330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":54,"alternative-id":["S0169500222004330"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.05.004","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}